ESPE2022 Poster Category 1 Thyroid (44 abstracts)
Molecular Characterisation of Patients with Thyroid Dyshormonogenesis and Variants in DUOX2
Noelia Baz-Redón 1 , Núria Camats-Tarruella 1,2 , Mónica Fernández-Cancio 1,2 , María Antolín 3 , Elena García-Arumí 3,2 , Eduard Mogas 1 , Ariadna Campos 1 , Anna Fàbregas 1 , Núria Gonzalez-Llorens 1 , Laura Soler 1 , María Clemente 1,2 & Diego Yeste 1,2
1Growth and Development Group, Vall d’Hebron Research Institute (VHIR) – Paediatric Endocrinology Unit, Hospital UniversitarioVall d’Hebron (HUVH), Barcelona, Spain; 2CIBERER, ISCIII, Madrid, Spain; 3Clinical and Molecular Genetics Area, HUVH, Barcelona, Spain
Introduction: Thyroid dyshormonogenesis (TD) is a heterogeneous group of genetic diseases caused by the total or partial defect in the synthesis or secretion of thyroid hormones. It presents clinical heterogeneity, from subclinical hypothyroidism (SH) to goitre. The clearer understanding of the pathways and enzymatic activities involved in the synthesis of thyroid hormones has allowed us to identify an important number of causal genes. Defective organification of iodine is caused by abnormalities of thyroglobulin, TPO synthesis, or H
Objectives: To undertake a molecular characterisation and genotype-phenotype correlation in patients with TD and candidate variants in the DUOX2.
Patients and Methods: 114 paediatric patients with congenital hypothyroidism from the Catalan Neonatal Screening Programme have been analysed using a high-throughput sequencing panel (Cell3 Target Custom Panel tier 2, NONACUS) including 14 genes.
Results: A total of 24 (21.1%) patients presented variants in the DUOX2 gene that could explain their phenotype. Eleven (45.8%) patients were heterozygous, six (25%) compound heterozygous, and four (16.7%) homozygous. In the remaining three patients, family segregation studies are required to confirm inheritance. In addition, seven (29.2%) of these patients presented variants in other genes, suggesting a possible digenic inheritance for TD: five patients presented variants in TG, one in DUOX1, and one in TPO. A total of 26 variants were described: 17 missense, 3 splicing, 3 frameshift, 2 nonsense, and 1 small deletion. Eleven (42.3%) of these variants have not been previously described in the literature. Sixteen (61.6%) were classified as variants of uncertain significance (VUS), seven (26.9%) as pathogenic, and three (11.5%) as probably pathogenic. The most frequent variant in our cohort has been c.2895_2898del/p.(Phe966SerfsTer29), classified as pathogenic according to reported functional studies. Ten of the 24 patients have been reevaluated, four were diagnosed with hyperthyrotropinemia, three had transient hypothyroidism, and four with permanent hypothyroidism (three mild and one severe). A clear genotype-phenotype correlation could not be identified; therefore, functional studies are being designed to analyse the H
Conclusion: 22.8% of patients with congenital hypothyroidism in our cohort presented variants in DUOX2. A clear genotype-phenotype correlation could not be described; therefore, clinical reevaluation of these patients is advisable. Alternatively, in vitro functional studies could be a useful tool to confirm the pathogenicity of the described genotypes.
Article tools
My recent searches
My recently viewed abstracts
Authors
ESPE Abstracts
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more